Clinical Investigation of Intermediate- and High-Purity Antihaemophilic Factor (Factor VIII) Concentrates
- 1 July 1971
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 21 (1), 21-41
- https://doi.org/10.1111/j.1365-2141.1971.tb03414.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Response of dogs to repeated intravenous injection of polyethylene glycol 4000 with notes on excretion and sensitizationToxicology and Applied Pharmacology, 1971
- Platelet Adhesiveness in von Willebrand’s DiseaseAmerican Journal of Clinical Pathology, 1969
- Treatment of Hemophilia B with a New Clotting-Factor ConcentrateNew England Journal of Medicine, 1969
- POOL'S CRYOPRECIPITATE AND EXHAUSTED PLASMA IN THE TREATMENT OF VON WILLEBRAND'S DISEASE AND FACTOR-XI DEFICIENCYThe Lancet, 1966
- Thrombin and the Interaction of Factors VIII and IXBritish Journal of Haematology, 1965
- EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATIONJournal of Neuropathology and Experimental Neurology, 1965
- The in vivo Longevity of Antihaemophilic Factor (Factor VIII)British Journal of Haematology, 1964
- Trace Metal Levels in Human Serum and BloodArchives of environmental health, 1963
- The Fate of Prothrombin and Factors VIII, IX and X Transfused to Patients Deficient in these FactorsBritish Journal of Haematology, 1963
- A Method for the Study of Antihaemophilic Globulin Inhibitors with Reference to Six CasesBritish Journal of Haematology, 1959